Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonaz Font

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Frontiers in Oncology|December 16, 2022
The promising prognostic value of vagal nerve activity at the initial management of ovarian cancerFrançois Cherifi, Sophie Lefevre Arbogast, Jonaz Font, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|April 24, 2025
Identification of Anticancer Drugs Associated to Cancer Therapy-Related Cardiac Dysfunction: A VigiBase® Disproportionality AnalysisDamien Legallois, Angélique Da Silva, Joachim Alexandre, et al.
Heart Rhythm|April 17, 2026
Twelve-month outcomes of cavotricuspid isthmus ablation using a pentaspline pulsed field ablation catheterJonaz Font, Laure Champ-Rigot, Virginie Ferchaud, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|September 26, 2025
Redefining the anatomy of the triangle of Koch for the implantation of a dual-chamber single-capsule leadless pacemakerPierre Ollitrault, Jonaz Font, Thomas Foulon, et al.
JACC. Case Reports|July 4, 2025
Emergency Pulsed-Field Ablation as a Bail-Out Strategy for Refractory Incessant VTPierre Ollitrault, Jonaz Font, Alina Denisenko, et al.
Leukemia|September 19, 2024
Is ibrutinib-related atrial fibrillation dose dependent? Insights from an individual case level analysis of the World Health Organization pharmacovigilance databaseJoachim Alexandre, Jonaz Font, Da-Silva Angélique, et al.
JACC. Cardiooncology|May 5, 2023
Atrial Fibrillation Incidence Associated With Exposure to Anticancer Drugs Used as Monotherapy in Clinical TrialsJoachim Alexandre, Louis Boismoreau, Pierre-Marie Morice, et al.
Experimental Hematology & Oncology|March 5, 2025
Ibrutinib and acalabrutinib use and risk of incident atrial fibrillation: a propensity-matched analysisJoachim Alexandre, Jonaz Font, Thibault Lenormand, et al.
BMJ Open|April 7, 2026
Identification of immunomodulators associated with atrial fibrillation reporting to better understand AF immunologic mechanisms: a Vigibase retrospective disproportionality analysis and a literature reviewJonaz Font, Charles Dolladille, Jordane Divoux, et al.
Archives of Cardiovascular Diseases|December 9, 2025
Temporal trends in atrial fibrillation catheter ablation efficacy: A systematic review, meta-analysis and meta-regression from more than 20years of clinical dataJonaz Font, Charles Dolladille, Damien Legallois, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Frontiers in Oncology|December 16, 2022
The promising prognostic value of vagal nerve activity at the initial management of ovarian cancerFrançois Cherifi, Sophie Lefevre Arbogast, Jonaz Font, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|April 24, 2025
Identification of Anticancer Drugs Associated to Cancer Therapy-Related Cardiac Dysfunction: A VigiBase® Disproportionality AnalysisDamien Legallois, Angélique Da Silva, Joachim Alexandre, et al.
Heart Rhythm|April 17, 2026
Twelve-month outcomes of cavotricuspid isthmus ablation using a pentaspline pulsed field ablation catheterJonaz Font, Laure Champ-Rigot, Virginie Ferchaud, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|September 26, 2025
Redefining the anatomy of the triangle of Koch for the implantation of a dual-chamber single-capsule leadless pacemakerPierre Ollitrault, Jonaz Font, Thomas Foulon, et al.
JACC. Case Reports|July 4, 2025
Emergency Pulsed-Field Ablation as a Bail-Out Strategy for Refractory Incessant VTPierre Ollitrault, Jonaz Font, Alina Denisenko, et al.
Leukemia|September 19, 2024
Is ibrutinib-related atrial fibrillation dose dependent? Insights from an individual case level analysis of the World Health Organization pharmacovigilance databaseJoachim Alexandre, Jonaz Font, Da-Silva Angélique, et al.
JACC. Cardiooncology|May 5, 2023
Atrial Fibrillation Incidence Associated With Exposure to Anticancer Drugs Used as Monotherapy in Clinical TrialsJoachim Alexandre, Louis Boismoreau, Pierre-Marie Morice, et al.
Experimental Hematology & Oncology|March 5, 2025
Ibrutinib and acalabrutinib use and risk of incident atrial fibrillation: a propensity-matched analysisJoachim Alexandre, Jonaz Font, Thibault Lenormand, et al.
BMJ Open|April 7, 2026
Identification of immunomodulators associated with atrial fibrillation reporting to better understand AF immunologic mechanisms: a Vigibase retrospective disproportionality analysis and a literature reviewJonaz Font, Charles Dolladille, Jordane Divoux, et al.
Archives of Cardiovascular Diseases|December 9, 2025
Temporal trends in atrial fibrillation catheter ablation efficacy: A systematic review, meta-analysis and meta-regression from more than 20years of clinical dataJonaz Font, Charles Dolladille, Damien Legallois, et al.
Pageof 3